Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
New research describes a preventive treatment paradox in advanced age
+Practice
In print
OLDER PEOPLE
New research describes a preventive treatment paradox in advanced age
Wednesday 16 March 2022, 12:35 AM

Women were found to be less likely to receive triple therapy [Image: SelectStock on iStock]
Professor Ngaire Kerse summarises recent research carried out at the University of Auckland into the use of cardiovascular disease preventive medications in people aged 65 and over
Key points, Recent research shows that the cardiovascular disease preventive medications most likely to cause harm are those most likely to be dispensed to older , Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
Wells S, Choi Y, Jackson R, et al. Cardiovascular disease preventive medication dispensing for almost every New Zealander 65 years and over: a preventive treatment paradox? Age Ageing 2022;51(1):afab265.